Wednesday, December 12, 2018

Abirapro 250mg tablet|Apple pharmaceuticals

Abirapro 250mg

Description

It is an antiandrogen medication which is used in the treatment of prostate cancer.The patient have received earlier chemotherapy with docetaxel combination with prednisone and in failure of androgen deprivation treatment.

Usage Of Abirapro

  The patient clinically not used for chemotherapy with prednisone or prednisolone will preferred treatment with metastatic CRPC in adult men.

abirapro-250-mg

Dosage & Administration

Abirapro tablets in Combination with prednisone 5 mg administered orally twice daily.
Abirapro Tablets administrated on an empty stomach.
• Abirapro should be swallowed whole with water.
• Do not crush or chew the tablets.

Mechanism Of Action

Particularily , abiraterone prevents the conversion of 17-hydroxyprognenolone to dehydroepiandrosterone (DHEA) by the enzyme CYP17A1 to reduce serum levels of testosterone and other androgens.A type of steroidal enzyme inhibitor CYP17A1 (17 alpha-hydroxylase/C17,20 lyase) is known as abirateron acetate which is an orally active and It interefere with CYP17A1 in a selective and invariable manner through covalent binding mechanism. An enzyme CYP17A1 which catalyzes the biosynthesis of androgen and is highly expressed in testicular, adrenal, and prostatic tumor tissue.

Drug Interaction

Drugs that inhibits or induce CYP3A4
Abiraterone interaction with strong CYP3A4inhibitors or inducers, the pharmacokinetics of Abiraterone is not evaluated properily, so avoid or use with caution while abiterone therapy.
Effects of Abiraterone on drug metabolizing enzymes
Abiraterone is a hepatic drug-metabolizing inhibitor CYP2D6, when substrates (dextromethorphan) of it is co administrated with Abiraterone will increases the Cmax and AUC dextromethorphan.

For  more Information

Contact us :   +91- 9987711567

Email         :  applepharmaceutical@gmail.com

No comments:

Post a Comment